biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$1.06+0.03 (+3.40%)
Close on Nov 13, 2026Market cap $38.26MP/E –Yield –
biote total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
biote's total debt was $120.07M at Sep 30, 2026. For fiscal 2025 it was $102.03M, down 5.0% from the year before. The highest annual figure on record is $118.34M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $102.03M | -5.0% |
| FY2024 | Dec 31, 2024 | $107.45M | -4.8% |
| FY2023 | Dec 31, 2023 | $112.88M | -4.6% |
| FY2022 | Dec 31, 2022 | $118.34M | +220.1% |
| FY2021 | Dec 31, 2021 | $36.96M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $120.07M | +16.1% |
| Q2 FY2026 | Jun 30, 2026 | $121.50M | +16.0% |
| Q1 FY2026 | Mar 31, 2026 | $100.68M | -5.1% |
| Q4 FY2025 | Dec 31, 2025 | $102.03M | -5.0% |
| Q3 FY2025 | Sep 30, 2025 | $103.38M | -5.0% |
| Q2 FY2025 | Jun 30, 2025 | $104.74M | -4.9% |
| Q1 FY2025 | Mar 31, 2025 | $106.10M | -4.9% |
| Q4 FY2024 | Dec 31, 2024 | $107.45M | -4.8% |
| Q3 FY2024 | Sep 30, 2024 | $108.80M | -4.8% |
| Q2 FY2024 | Jun 30, 2024 | $110.16M | -4.7% |
| Q1 FY2024 | Mar 31, 2024 | $111.52M | -4.7% |
| Q4 FY2023 | Dec 31, 2023 | $112.88M | -4.6% |
| Q3 FY2023 | Sep 30, 2023 | $114.24M | -4.6% |
| Q2 FY2023 | Jun 30, 2023 | $115.60M | -4.5% |
| Q1 FY2023 | Mar 31, 2023 | $116.97M | +216.4% |
| Q4 FY2022 | Dec 31, 2022 | $118.34M | – |
| Q3 FY2022 | Sep 30, 2022 | $119.70M | – |
| Q2 FY2022 | Jun 30, 2022 | $121.06M | – |
| Q4 FY2021 | Dec 31, 2021 | $36.96M | – |
See a number that looks wrong?